Results 321 to 330 of about 5,263,232 (399)
State-of-the-Art Imaging in Antibody-Drug Conjugate Treatment for Advanced Bladder Cancer. [PDF]
Eid S +7 more
europepmc +1 more source
Impacts of Diets and Food Plans in Health and Diseases—A Narrative Review
This review emphasizes different diet types, providing insights into their nutritional content and health effects. Vegetarian and vegan diets, ketogenic diets, Mediterranean diets, Western diets, pescatarian diets, flexitarian diets, and territorial diversified diets are discussed, highlighting their influences on health, and diseases.
Md. Mahbubar Rahman +3 more
wiley +1 more source
Ensemble machine learning models for predicting bone metastasis in bladder cancer. [PDF]
Yu ZJ +5 more
europepmc +1 more source
ABSTRACT Background The loss of the Y chromosome (LOY) and the extreme down‐regulation of Y chromosome gene expression (EDY) are frequently observed in oral squamous cell carcinoma (OSCC). However, their roles in oral potentially malignant disorders (OPMDs) are unclear.
Rui Han +6 more
wiley +1 more source
ACTG1 driven splicing of P4HB gene enhances EMT and bladder cancer progression. [PDF]
Liu Z +6 more
europepmc +1 more source
Novel Strategies and Therapeutic Advances for Bladder Cancer. [PDF]
Ehrlich MI +4 more
europepmc +1 more source
Whats New? This observational study of the incidence trends of malignancy by site, stratified by age group and sex, over three decades in a large northern Italian population reveals a heterogeneous landscape among younger adults (aged under 50). Invasive cutaneous melanoma in both sexes, testicular cancer and multiple myeloma in males, and breast ...
Alessandra Buja +9 more
wiley +1 more source
Tropomyosin Isoforms as Biomarkers for Urothelial Bladder Cancer: Promise and Challenges. [PDF]
Akintelure D +3 more
europepmc +1 more source
The role of cytokines in ovarian cancer drug resistance
Abstract Ovarian cancer is the leading cause of death among women diagnosed with female reproductive system cancers. While significant advances have been made in treating various types of cancer, progress in ovarian cancer treatment over the past 20 years has been minimal, and the treatment course of ovarian cancer is not linear. Although many patients
Lu Wang +7 more
wiley +1 more source

